BE vs HEI

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full distress risk assessment. Despite explosive revenue growth of 57.1% and strong recent earnings surprises, the company trades at extreme valuations (P/E of 2069, P/B of 52.44) far above sector averages, while profitability remains thin (ROE: 2.93%, net margin: 0.84%). Aggressive insider selling worth $20.85M over the past six months and a bearish technical trend (10/100) further signal caution. Although analysts recommend a 'buy', the stock appears significantly overvalued relative to both defensive (Graham Number: $2.09) and growth-based intrinsic value ($0.49), suggesting elevated downside risk.

HEI demonstrates strong fundamental health with a Piotroski F-Score of 7/9 and exceptional liquidity (Current Ratio 3.06). However, the stock is severely overvalued by deterministic standards, trading significantly above its Graham Number ($60.64) and Intrinsic Value ($130.29). While the company maintains a stellar track record of earnings beats and steady growth, the current technical trend is bearish (0/100) and the PEG ratio of 2.46 indicates a steep premium. The disconnect between fundamental value and market price suggests a high-quality company at an unattractive entry point.